Cargando…
SARS-CoV-2 (COVID-19) and audio-vestibular disorders
To describe the audio-vestibular disorders related to the newly SARS-CoV-2 infection, including the possible ototoxicity side-effects related to the use of drugs included in the SARS-CoV-2 treatment protocols. A systematic review was performed according to the PRISMA protocol. The Medline and Embase...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216371/ https://www.ncbi.nlm.nih.gov/pubmed/34142589 http://dx.doi.org/10.1177/20587384211027373 |
_version_ | 1783710404599349248 |
---|---|
author | Fancello, Virginia Hatzopoulos, Stavros Corazzi, Virginia Bianchini, Chiara Skarżyńska, Magdalena B Pelucchi, Stefano Skarżyński, Piotr Henryk Ciorba, Andrea |
author_facet | Fancello, Virginia Hatzopoulos, Stavros Corazzi, Virginia Bianchini, Chiara Skarżyńska, Magdalena B Pelucchi, Stefano Skarżyński, Piotr Henryk Ciorba, Andrea |
author_sort | Fancello, Virginia |
collection | PubMed |
description | To describe the audio-vestibular disorders related to the newly SARS-CoV-2 infection, including the possible ototoxicity side-effects related to the use of drugs included in the SARS-CoV-2 treatment protocols. A systematic review was performed according to the PRISMA protocol. The Medline and Embase databases were searched from March 1, 2020 to April 9, 2021. Initially the search yielded 400 manuscripts, which were reduced to 15, upon the application of inclusion criteria. Sensorineural hearing loss (SNHL) is the most frequent audio-vestibular symptom described, occurring alone or in association with tinnitus and vertigo. The etiopathogenesis of the inner ear disorders related to COVID-19 infection is still poorly understood. The number of reports of COVID-19 infections associated to audio-vestibular disorders is increasing; even if the quality of the studies available is often insufficient, audio-vestibular disorders should be considered as possible manifestations to be included among the symptoms of this infection. |
format | Online Article Text |
id | pubmed-8216371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82163712021-06-30 SARS-CoV-2 (COVID-19) and audio-vestibular disorders Fancello, Virginia Hatzopoulos, Stavros Corazzi, Virginia Bianchini, Chiara Skarżyńska, Magdalena B Pelucchi, Stefano Skarżyński, Piotr Henryk Ciorba, Andrea Int J Immunopathol Pharmacol Inflammatory Mediators in COVID-19 and Other Diseases To describe the audio-vestibular disorders related to the newly SARS-CoV-2 infection, including the possible ototoxicity side-effects related to the use of drugs included in the SARS-CoV-2 treatment protocols. A systematic review was performed according to the PRISMA protocol. The Medline and Embase databases were searched from March 1, 2020 to April 9, 2021. Initially the search yielded 400 manuscripts, which were reduced to 15, upon the application of inclusion criteria. Sensorineural hearing loss (SNHL) is the most frequent audio-vestibular symptom described, occurring alone or in association with tinnitus and vertigo. The etiopathogenesis of the inner ear disorders related to COVID-19 infection is still poorly understood. The number of reports of COVID-19 infections associated to audio-vestibular disorders is increasing; even if the quality of the studies available is often insufficient, audio-vestibular disorders should be considered as possible manifestations to be included among the symptoms of this infection. SAGE Publications 2021-06-18 /pmc/articles/PMC8216371/ /pubmed/34142589 http://dx.doi.org/10.1177/20587384211027373 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Inflammatory Mediators in COVID-19 and Other Diseases Fancello, Virginia Hatzopoulos, Stavros Corazzi, Virginia Bianchini, Chiara Skarżyńska, Magdalena B Pelucchi, Stefano Skarżyński, Piotr Henryk Ciorba, Andrea SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title | SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title_full | SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title_fullStr | SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title_full_unstemmed | SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title_short | SARS-CoV-2 (COVID-19) and audio-vestibular disorders |
title_sort | sars-cov-2 (covid-19) and audio-vestibular disorders |
topic | Inflammatory Mediators in COVID-19 and Other Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216371/ https://www.ncbi.nlm.nih.gov/pubmed/34142589 http://dx.doi.org/10.1177/20587384211027373 |
work_keys_str_mv | AT fancellovirginia sarscov2covid19andaudiovestibulardisorders AT hatzopoulosstavros sarscov2covid19andaudiovestibulardisorders AT corazzivirginia sarscov2covid19andaudiovestibulardisorders AT bianchinichiara sarscov2covid19andaudiovestibulardisorders AT skarzynskamagdalenab sarscov2covid19andaudiovestibulardisorders AT pelucchistefano sarscov2covid19andaudiovestibulardisorders AT skarzynskipiotrhenryk sarscov2covid19andaudiovestibulardisorders AT ciorbaandrea sarscov2covid19andaudiovestibulardisorders |